Topic: Glaxosmithkline

Professor Jason Schwartz of Yale University criticized the CDC's Hepatitis B recommendation on the BBC, arguing it creates confusion and undermines public health infrastructure. The segment notes that the primary manufacturers of the vaccine are British companies like GlaxoSmithKline, which may explain the BBC's significant interest in the US policy change. Critics of the new policy worry it will lead to a broader decline in childhood immunization rates.

Tucker Carlson interviews a functional medicine doctor who claims pharmaceutical companies buy TV advertising not to sell drugs, but to "buy off" news networks and prevent investigative reporting. The hosts play a clip from 2011 where they made the same observation, noting that the U.S. is one of only two countries that allow direct-to-consumer prescription drug ads. They argue the media has been "captured" by the medical-industrial complex.

A "boots on the ground" report from a physician in the Netherlands describes a Pfizer-sponsored lunch aimed at raising awareness for RSV vaccines. The report notes that while RSV is common in infants, it is rarely a cause for hospitalization in the elderly, yet it is being marketed to seniors to "gouge" government healthcare systems. The hosts discuss the financial incentives for doctors to push unnecessary shots to Medicare recipients.

An FDA advisory panel voted 14-0 to recommend Pfizer’s maternal RSV vaccine, though the safety vote was a narrower 10-4 due to concerns over preterm births. Competitor GlaxoSmithKline previously paused its own RSV vaccine trials following "significant safety signals," including neonatal deaths. The vaccine is intended for administration to pregnant women to protect infants for their first six months of life.

Pharmacies across the US are reporting severe shortages of Tamiflu and children's Tylenol during a worsening flu season. While Relenza is a viable alternative, it is rarely mentioned in mainstream media reports. Additionally, an industry whistleblower claims that two nano-lipids used in the Pfizer vaccine were never approved for human use and may be accumulating in the livers of recipients.

Drawing from a James Corbett documentary, the hosts detail a 2009 Gates-funded HPV vaccine study in India that was investigated for human rights violations and lack of informed consent. The Indian government eventually cut ties with the Gates Foundation's advisory group in 2017 due to conflicts of interest and the perception that Indian citizens were being used as "guinea pigs" for Big Pharma.

Dr. Deborah Birx has accepted a position with Active Pure Technology, a Texas-based company seeking FDA clearance for air purifiers to remove coronavirus particles. She also joined the board of Inoviva, an investment firm that collects royalties from GlaxoSmithKline medicines, and the George W. Bush Institute.

Google's parent company, Alphabet, is reportedly intertwined with the pharmaceutical industry through a $750 million deal with GlaxoSmithKline. Kennedy alleges that Google uses its search algorithms to censor alternative health information, such as vitamins or chiropractic care, to protect the allopathic pharmaceutical paradigm. Furthermore, the CDC is noted to be heavily funded by the very companies it regulates.

Representative Adam Schiff reportedly pressured tech giants like Facebook, Google, and Amazon to censor "misinformation" regarding vaccines. Adam Curry highlights a $668 million partnership between Google and GlaxoSmithKline as a potential conflict of interest. The discussion centers on the lack of placebo-controlled safety trials for the 72 vaccines currently mandated for children.

GlaxoSmithKline has invested $300 million in 23andMe to gain access to its database of 5 million customers for drug research. The hosts warn that DNA data is the ultimate personal information and express concern that these databases will inevitably be hacked or sold to "bad actors" in the pharmaceutical industry.

European regulators give a green light to "Mosquirix," the first malaria vaccine, developed by GlaxoSmithKline and the nonprofit PATH. The hosts express skepticism about the vaccine's efficacy and the involvement of the Gates Foundation. They note that the vaccine is intended for use in young children in Africa.

The CDC issued a rare apology, admitting that the 2014-2015 flu vaccine is largely ineffective because the virus mutated. Despite the failure, health officials are urging the use of antiviral drugs like Tamiflu and Relenza, which critics see as a sales pitch for pharmaceutical companies. The hosts discuss the side effects of these drugs and advocate for Vitamin D3 therapy as a more effective preventative measure.

GlaxoSmithKline CEO Sir Andrew Witty discusses the unprecedented pace of developing an Ebola vaccine, aiming for doses to be available by Christmas 2014. Witty emphasizes the need for government indemnification because the vaccine will be used in emergency situations before traditional long-term trials are completed. The hosts express skepticism regarding the sudden "cracking" of the vaccine code and the financial motivations involved.

Speculation arises that the Ebola crisis serves as a pretext for deploying combat troops to West Africa to secure oil and mineral interests. Meanwhile, an accidental release of 45 liters of concentrated live poliovirus by GlaxoSmithKline in Rixensart, Belgium, occurred on September 2, 2014. Additionally, Nation of Islam leader Louis Farrakhan claims the Ebola virus was designed by scientists to target specific populations.

The FDA has approved a GlaxoSmithKline H5N1 bird flu vaccine containing the adjuvant AS03 for the national stockpile. The hosts discuss the history of adjuvants like squalene and link them to cases of narcolepsy in European children following the 2009 swine flu vaccinations.

An examination of USADA's leadership reveals deep ties to major pharmaceutical companies like GlaxoSmithKline and Baxter International. CEO Travis Tygart's compensation and the agency's research grants are scrutinized. The hosts conclude that USADA functions more as a pharmaceutical research and lobbying arm than a simple sports regulator.

The Wellcome Trust released a report titled "ADHD Voices," which uses colorful illustrations and child interviews to promote the benefits of Ritalin and other stimulants. Critics argue the report is a sophisticated marketing tool designed to normalize the drugging of children to improve academic performance. The history of the Wellcome Trust's ties to the pharmaceutical industry is examined.

GlaxoSmithKline agreed to a $3 billion settlement, the largest healthcare fraud case in U.S. history, for illegally marketing drugs like Wellbutrin and Paxil. It was revealed that celebrity doctor Drew Pinsky was paid $275,000 to promote Wellbutrin for unapproved uses on his radio show. Despite the company's claims that such practices are a "bygone era," the hosts argue that pharmaceutical shilling remains rampant in the media.

The United States has joined a World Health Organization framework for global vaccine sharing, which involves donating surplus drugs to poorer nations. Meanwhile, the GlaxoSmithKline vaccine Pandemrix has been linked to cases of narcolepsy in children in Finland and other countries. Legal protections generally prevent pharmaceutical companies from being sued for vaccine-related injuries, leading to mandatory label changes rather than litigation.

Health Secretary Andrew Lansley faces pressure in the United Kingdom as swine flu deaths reach 39 for the season. The hosts question the persistence of the H1N1 strain and argue that pharmaceutical companies like GlaxoSmithKline prioritize vaccines over cures due to higher profit margins. A comparison is made to the "wine game," where low-quality products are sold with the promise of future improvement.